Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis

PLoS Pathogens

Volumn 8, Issue 4, 2012, Pages

  Schelhaas, Mario ^a,b   Shah, Bhavin ^a   Holzer, Michael ^b   Blattmann, Peter ^b   Kühling, Lena ^a   Day, Patricia M ^c   Schiller, John T ^c   Helenius, Ari ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ETH ZURICH   (Switzerland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CAVEOLIN 1; CHOLESTEROL; CLATHRIN; DYNAMIN; FLOTILLIN 1; P21 ACTIVATED KINASE 1; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; CAVEOLIN; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN; SODIUM PROTON EXCHANGE PROTEIN;

ACTIN POLYMERIZATION; ARTICLE; CATION EXCHANGE; CELL MIGRATION; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPOLYMERIZATION; ENDOCYTOSIS; ENDOSOME; EPITHELIUM CELL; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INFLUENZA VIRUS A; LIPID RAFT; LYSOSOME; NONHUMAN; PH; PINOCYTOSIS; SEMLIKI FOREST ALPHAVIRUS; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS ENTRY; CELL MEMBRANE; GENETICS; METABOLISM; PAPILLOMAVIRUS INFECTION; PHYSIOLOGY;

HUMAN PAPILLOMAVIRUS TYPE 16; INFLUENZA A VIRUS; SEMLIKI FOREST VIRUS; SIMIAN VIRUS 40; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

ACTINS; CAVEOLINS; CLATHRIN; ENDOCYTOSIS; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEMBRANE MICRODOMAINS; P21-ACTIVATED KINASES; PAPILLOMAVIRUS INFECTIONS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; VIRUS INTERNALIZATION;

EID: 84861207605     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002657     Document Type: Article

References (82)

1. Longworth MS, Laimins LA, (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68: 362-372.
2. Sapp M, Day PM, (2009) Structure, attachment and entry of polyoma- and papillomaviruses. Virology 384: 400-409.
3. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, et al. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13: 857-861.
4. Abban CY, Bradbury NA, Meneses PI, (2008) HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. Am J Ther 15: 304-311.
5. Bousarghin L, Touze A, Sizaret PY, Coursaget P, (2003) Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol 77: 3846-3850.
6. Day PM, Lowy DR, Schiller JT, (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307: 1-11.
7. Schelhaas M, Ewers H, Rajamaki ML, Day PM, Schiller JT, et al. (2008) Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog 4: e1000148.
8. Smith JL, Campos SK, Ozbun MA, (2007) Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol 81: 9922-9931.
9. Spoden G, Freitag K, Husmann M, Boller K, Sapp M, et al. (2008) Clathrin- and caveolin-independent entry of human papillomavirus type 16-involvement of tetraspanin-enriched microdomains (TEMs). PLoS One 3: e3313.
10. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT, (2005) Maturation of papillomavirus capsids. J Virol 79: 2839-2846.
11. Buck CB, Thompson CD, Roberts JN, Muller M, Lowy DR, et al. (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2: e69.
12. Combita AL, Touze A, Bousarghin L, Sizaret PY, Munoz N, et al. (2001) Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett 204: 183-188.
13. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M, (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75: 1565-1570.
14. Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, et al. (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83: 2067-2074.
15. Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND, (2006) Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80: 8940-8950.
16. Bienkowska-Haba M, Patel HD, Sapp M, (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5: e1000524.
17. Richards RM, Lowy DR, Schiller JT, Day PM, (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103: 1522-1527.
18. Day PM, Gambhira R, Roden RB, Lowy DR, Schiller JT, (2008) Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol 82: 4638-4646.
19. Day PM, Lowy DR, Schiller JT, (2008) Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol 82: 12565-12568.
20. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM, (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci U S A 106: 20458-20463.
21. Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, et al. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81: 10970-10980.
22. Hindmarsh PL, Laimins LA, (2007) Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J 4: 19.
23. Selinka HC, Giroglou T, Sapp M, (2002) Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299: 279-287.
24. Culp TD, Christensen ND, (2004) Kinetics of in vitro adsorption and entry of papillomavirus virions. Virology 319: 152-161.
25. Ruthardt N, Lamb DC, Brauchle C, (2011) Single-particle tracking as a quantitative microscopy-based approach to unravel cell entry mechanisms of viruses and pharmaceutical nanoparticles. Mol Ther 19: 1199-1211.
26. Burckhardt CJ, Greber UF, (2009) Virus movements on the plasma membrane support infection and transmission between cells. PLoS Pathog 5: e1000621.
27. Culp TD, Budgeon LR, Christensen ND, (2006) Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 347: 147-159.
28. Taylor MJ, Perrais D, Merrifield CJ, (2011) A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis. PLoS Biol 9: e1000604.
29. Merrifield CJ, Feldman ME, Wan L, Almers W, (2002) Imaging actin and dynamin recruitment during invagination of single clathrin-coated pits. Nat Cell Biol 4: 691-698.
30. DeTulleo L, Kirchhausen T, (1998) The clathrin endocytic pathway in viral infection. EMBO J 17: 4585-4593.
31. Doxsey SJ, Brodsky FM, Blank GS, Helenius A, (1987) Inhibition of endocytosis by anti-clathrin antibodies. Cell 50: 453-463.
32. Marsh M, Helenius A, (1980) Adsorptive endocytosis of Semliki Forest virus. J Mol Biol 142: 439-454.
33. Sieczkarski SB, Whittaker GR, (2002) Dissecting virus entry via endocytosis. J Gen Virol 83: 1535-1545.
34. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, et al. (2005) Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 168: 477-488.
35. Engel S, Heger T, Mancini R, Herzog F, Kartenbeck J, et al. (2011) Role of endosomes in simian virus 40 entry and infection. J Virol 85: 4198-4211.
36. Pelkmans L, Kartenbeck J, Helenius A, (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3: 473-483.
37. Marsh M, Bolzau E, Helenius A, (1983) Penetration of Semliki Forest virus from acidic prelysosomal vacuoles. Cell 32: 931-940.
38. Hansen CG, Nichols BJ, (2009) Molecular mechanisms of clathrin-independent endocytosis. J Cell Sci 122: 1713-1721.
39. Glebov OO, Bright NA, Nichols BJ, (2006) Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat Cell Biol 8: 46-54.
40. Pelkmans L, Burli T, Zerial M, Helenius A, (2004) Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118: 767-780.
41. Doherty GJ, McMahon HT, (2009) Mechanisms of endocytosis. Annu Rev Biochem 78: 857-902.
42. Mercer J, Schelhaas M, Helenius A, (2010) Virus Entry by Endocytosis. Annu Rev Biochem 79: 803-833.
43. Yang R, Yutzy WHt, Viscidi RP, Roden RB, (2003) Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. J Biol Chem 278: 12546-12553.
44. Mercer J, Helenius A, (2009) Virus entry by macropinocytosis. Nat Cell Biol 11: 510-520.
45. Niedergang F, Chavrier P, (2005) Regulation of phagocytosis by Rho GTPases. Curr Top Microbiol Immunol 291: 43-60.
46. Mercer J, Helenius A, (2008) Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 320: 531-535.
47. Mercer J, Knebel S, Schmidt FI, Crouse J, Burkard C, et al. (2010) Vaccinia virus strains use distinct forms of macropinocytosis for host-cell entry. Proc Natl Acad Sci U S A 107: 9346-9351.
48. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG, (2001) Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 154: 1007-1017.
49. Naslavsky N, Weigert R, Donaldson JG, (2004) Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirements. Mol Biol Cell 15: 3542-3552.
50. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, et al. (1999) Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 99: 521-532.
51. Schelhaas M, (2010) Come in and take your coat off - how host cells provide endocytosis for virus entry. Cell Microbiol 12: 1378-1388.
52. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, et al. (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274: 5810-5822.
53. Smith JL, Campos SK, Wandinger-Ness A, Ozbun MA, (2008) Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol 82: 9505-9512.
54. Ohkuma S, Poole B, (1978) Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 75: 3327-3331.
55. Sieczkarski SB, Whittaker GR, (2003) Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4: 333-343.
56. Day PM, Baker CC, Lowy DR, Schiller JT, (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A 101: 14252-14257.
57. Johannsdottir HK, Mancini R, Kartenbeck J, Amato L, Helenius A, (2009) Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol 83: 440-453.
58. Kartenbeck J, Stukenbrok H, Helenius A, (1989) Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 109: 2721-2729.
59. Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, et al. (2007) Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131: 516-529.
60. Volpers C, Unckell F, Schirmacher P, Streeck RE, Sapp M, (1995) Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol 69: 3258-3264.
61. Fahey LM, Raff AB, Da Silva DM, Kast WM, (2009) A major role for the minor capsid protein of human papillomavirus type 16 in immune escape. J Immunol 183: 6151-6156.
62. Fothergill T, McMillan NA, (2006) Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology 352: 319-328.
63. Abban CY, Meneses PI, (2010) Usage of heparan sulfate, integrins, and FAK in HPV16 infection. Virology 403: 1-16.
64. Elferink JG, (1979) Chlorpromazine inhibits phagocytosis and exocytosis in rabbit polymorphonuclear leukocytes. Biochem Pharmacol 28: 965-968.
65. Watanabe S, Hirose M, Miyazaki A, Tomono M, Takeuchi M, et al. (1988) Calmodulin antagonists inhibit the phagocytic activity of cultured Kupffer cells. Lab Invest 59: 214-218.
66. Walenga RW, Opas EE, Feinstein MB, (1981) Differential effects of calmodulin antagonists on phospholipases A2 and C in thrombin-stimulated platelets. J Biol Chem 256: 12523-12528.
67. Amyere M, Payrastre B, Krause U, Van Der Smissen P, Veithen A, et al. (2000) Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol Biol Cell 11: 3453-3467.
68. Giocondi MC, Mamdouh Z, Le Grimellec C, (1995) Benzyl alcohol differently affects fluid phase endocytosis and exocytosis in renal epithelial cells. Biochim Biophys Acta 1234: 197-202.
69. Laniosz V, Dabydeen SA, Havens MA, Meneses PI, (2009) Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J Virol 83: 8221-8232.
70. Kerr MC, Teasdale RD, (2009) Defining macropinocytosis. Traffic 10: 364-371.
71. Marusic MB, Ozbun MA, Campos SK, Myers MP, Banks L, (2011) Human Papillomavirus L2 facilitates viral escape from late endosomes via Sorting Nexin 17. Traffic 13: 455-67.
72. Dabydeen SA, Meneses PI, (2009) The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection. Virol J 6: 109.
73. Kamper N, Day PM, Nowak T, Selinka HC, Florin L, et al. (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80: 759-768.
74. Schneider MA, Spoden GA, Florin L, Lambert C, (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13: 32-46.
75. Matlin KS, Reggio H, Helenius A, Simons K, (1981) Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91: 601-613.
76. Rust MJ, Lakadamyali M, Zhang F, Zhuang X, (2004) Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 11: 567-573.
77. de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jimenez V, Scholte F, et al. (2011) Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 7: e1001329.
78. Karjalainen M, Kakkonen E, Upla P, Paloranta H, Kankaanpaa P, et al. (2008) A Raft-derived, Pak1-regulated entry participates in alpha2beta1 integrin-dependent sorting to caveosomes. Mol Biol Cell 19: 2857-2869.
79. Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, et al. (2008) Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology 378: 21-33.
80. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT, (2005) Maturation of papillomavirus capsids. J Virol 79: 2839-46.
81. Eierhoff T, Hrincius ER, Rescher U, Ludwig S, Ehrhardt C, (2010) The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog 6: e1001099.
82. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, et al. (2004) Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells. Biophys J 86: 3993-4003.